MassIVE MSV000099018

Partial Public PXD068037

Human Apolipoprotein E4 Drives Female Disrupted Osteocyte Function and Bone Fragility

Subscribe Comment Convert Spectra Add Reanalysis

Description

Individuals diagnosed with Alzheimers Disease - AD are at an increased risk of bone fracture. Conversely, a diagnosis of osteoporosis in females is the earliest known predictor for AD. However, mechanisms responsible for the coupled decline in cognitive and skeletal health remain unclear. In proteomic analysis of aged mouse cortical bone, we unexpectedly find several neurological disease-associated factors, including apolipoprotein E , amyloid precursor protein, and others, in the 10 percent most abundant proteins. APOE localizes specifically to bone-embedded osteocytes, with expression in aged female bone exceeding that in young or male counterparts. In humans, APOE allele variants carry differing AD risk with age. To investigate their role in bone, we used a humanized APOE knock-in mouse model that expresses the protective APOE2, neutral APOE3, or AD risk factor APOE4 alleles. APOE4 exerts strong sex-specific effects on the bone transcriptome and proteome, relative to APO2 or APOE3. APOE4-dependent disruption of the female bone proteome is an order of magnitude more severe than in hippocampus of the same mice. The APOE4 allele causes bone fragility in females, but not males, prior to age-related losses to bone mass or cognition. This bone quality deficit arises from deregulation of osteocyte function and suppression of perilacunocanalicular remodeling. Our finding suggest that osteocyte-driven regulation of bone quality is an early and under appreciated target of APOE4, preceding cognitive decline and disproportionately affecting females. Thus, bone may provide new strategies to understand and intervene in age-related cognitive decline. [doi:10.25345/C5736MF5P] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: Bone ; Osteocytes ; Alzheimer's Disease ; Apoplipoprotein E ; DatasetType:Proteomics

Contact

Principal Investigators:
(in alphabetical order) 		Birgit Schilling, Buck Institute, USA
Submitting User: cschurman
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
Browse Quantification Results
 
FTP Download Link (click to copy):

Species

Instrument

Modifications

- Dataset Reanalyses

+ Dataset History

Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.